- Home
- CCL vs ILMN Comparison
CCL vs ILMN Comparison
Compare CCL & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCL | ILMN |
|---|---|---|
| Founded | 1972 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.0B | 37.0B |
| IPO Year | 1994 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CCL | ILMN |
|---|---|---|
| Price | $26.29 | $276.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 29 | 21 |
| Target Price | $33.93 | ★ $232.15 |
| AVG Volume (30 Days) | ★ 21.9M | 2.8M |
| Earning Date | 09-29-2026 | 10-29-2026 |
| Dividend Yield | ★ 2.30% | N/A |
| EPS Growth | 40.28 | ★ 170.87 |
| EPS | 1.96 | ★ 2.22 |
| Revenue | ★ $18,881,000,000.00 | $4,343,000,000.00 |
| Revenue This Year | $4.20 | $6.48 |
| Revenue Next Year | $3.12 | $6.46 |
| P/E Ratio | ★ $13.33 | $119.18 |
| Revenue Growth | ★ 7.83 | N/A |
| 52 Week Low | $21.45 | $88.00 |
| 52 Week High | $34.03 | $309.35 |
Technical Indicators
Market Signals| Indicator | CCL | ILMN |
|---|---|---|
| Relative Strength Index (RSI) | 64.50 | 62.08 |
| Support Level | $25.34 | $118.76 |
| Resistance Level | $28.22 | N/A |
| Average True Range (ATR) | 0.75 | 15.16 |
| MACD | 0.49 | -0.76 |
| Stochastic Oscillator | 91.35 | 55.42 |
Price Performance
Historical ComparisonAbout CCL Carnival Corporation
Carnival is the largest global cruise company, with nearly 100 ships in service. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It recently folded its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted nearly 14 million guests in 2025.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.